日本における真性赤血球増多症の治療の現況と予後

DOI Web Site PubMed 被引用文献1件

書誌事項

タイトル別名
  • Treatment and Prognosis of Polycythema Vera in Japan
  • ニホン ニ オケル シンセイ セッケッキュウ ゾウ タショウ ノ チリョウ ノ ゲンキョウ ト ヨゴ

この論文をさがす

抄録

Data of 217 patients with polycythemia vera diagnosed since 1960 were collected in Japan. The mean age of diagnosis was 53.0 years and a male: female ratio was 1.1:1.<br>Forty six patients were treated with P32 and 133 patients were treated by chemotherapy. In the course of chemotherapy busulfan was used most frequently.<br>The survival rate of the series was 75 per cent at 5 years and 55 per cent at 10 years after diagnosis. The survival was shorter in older patients and in those who had hypertension. After an adjustment for the age of patients was made, there was no difference between the survival of patients treated with P32 and that of patients treated by chemotherapy.<br>Of 31 patients who had died, the cause of death were vascular lesions in 8, anemia (myelofibrosis or aplastic anemia) in 4, acute leukemia in 2, cancer in 2, and others.

収録刊行物

  • 臨床血液

    臨床血液 15 (3), 243-248, 1974

    一般社団法人 日本血液学会

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ